Danijela Tasic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danijela Tasic has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Zorica Dimitrijevic
Clinic for Nephrology, University Clinical Center Nis, Bulevar dr Zorana Djindjica 48, 18000 Nis, Serbia
9 shared publications Sonja Radenkovic
Clin Ctr Nis, Clin Nephrol Dialysis & Transplantat, Nish, Serbia
3 shared publications- Tamara Vrecic
Clinic for Nephrology, University Clinical Center Nis, Bulevar dr Zorana Djindjica 48, 18000 Nis, Serbia
3 shared publications - Branka Mitic
Clinic for Nephrology, University Clinical Center Nis, Bulevar dr Zorana Djindjica 48, 18000 Nis, Serbia
2 shared publications - Dijana Stojanovic
Department of Pathophysiology Faculty of Medicine University of Niši Nis Serbia
2 shared publications - Gordana Kocic
Department of Biochemistry, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
2 shared publications
Latest Publications
- Open Access
Sarcopenia and 24-Month All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: A Prospective Observational Cohort Study Applying the Revised European Working Group on Sarcopenia in Older People Criteria
Background and Objectives: Sarcopenia is common among patients receiving maintenance hemodialysis, although prevalence estimates vary according to the diagnostic approach. We assessed sarcopenia defined according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2) criteria, its baseline correlates, and its association with 24-month all-cause mortality. Materials and Methods: In this single-center prospective cohort at a tertiary nephrology center, 176 patients enrolled in December 2022 were followed for 24 months. Confirmed sarcopenia required both low handgrip strength and a low appendicular skeletal muscle index assessed by bioelectrical impedance. Physical performance was not assessed. Because the proportional-hazards assumption was not satisfied, restricted mean survival time (RMST) was used as the primary measure of the survival difference. Results: Sarcopenia was present in 46 of 176 participants (26.1%, 95% CI 20.2–33.1). Older age, lower serum albumin and phosphorus concentrations, lower Kt/V, and longer time on maintenance hemodialysis were independently associated with sarcopenia. Thirty-one participants died during follow-up, and survival was lower among those with sarcopenia (log-rank p = 0.035). The adjusted RMST difference was −3.88 months (95% CI −6.49 to −1.28; p = 0.003). A Cox sensitivity analysis yielded a hazard ratio of 2.62 (95% CI 1.06–6.45). There was no evidence of a sarcopenia-by-sex interaction in the adjusted RMST analysis (p = 0.964). Conclusions: Confirmed sarcopenia was present in approximately one quarter of patients and was associated with approximately four months shorter restricted mean survival over 24 months. EWGSOP2-based assessment may provide prognostic information in this setting; whether routine screening or management based on sarcopenia status improves clinical outcomes remains to be determined.
Open AccessSarcopenia and 24-Month All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: A Prospective Observational Cohort Study Applying the Revised European Working Group on Sarcopenia in Older People Criteria
Background and Objectives: Sarcopenia is common among patients receiving maintenance hemodialysis, although prevalence estimates vary according to the diagnostic approach. We assessed sarcopenia defined according to the revised European Working Group on Sarcopenia in Older People (EWGSOP2) criteria, its baseline correlates, and its association with 24-month all-cause mortality. Materials and Methods: In this single-center prospective cohort at a tertiary nephrology center, 176 patients enrolled in December 2022 were followed for 24 months. Confirmed sarcopenia required both low handgrip strength and a low appendicular skeletal muscle index assessed by bioelectrical impedance. Physical performance was not assessed. Because the proportional-hazards assumption was not satisfied, restricted mean survival time (RMST) was used as the primary measure of the survival difference. Results: Sarcopenia was present in 46 of 176 participants (26.1%, 95% CI 20.2–33.1). Older age, lower serum albumin and phosphorus concentrations, lower Kt/V, and longer time on maintenance hemodialysis were independently associated with sarcopenia. Thirty-one participants died during follow-up, and survival was lower among those with sarcopenia (log-rank p = 0.035). The adjusted RMST difference was −3.88 months (95% CI −6.49 to −1.28; p = 0.003). A Cox sensitivity analysis yielded a hazard ratio of 2.62 (95% CI 1.06–6.45). There was no evidence of a sarcopenia-by-sex interaction in the adjusted RMST analysis (p = 0.964). Conclusions: Confirmed sarcopenia was present in approximately one quarter of patients and was associated with approximately four months shorter restricted mean survival over 24 months. EWGSOP2-based assessment may provide prognostic information in this setting; whether routine screening or management based on sarcopenia status improves clinical outcomes remains to be determined.
- Open Access
- 25 January 2026
- Published by Taylor & Francis in Platelets
- Vol. 37 (1) , 2614709
Prediction of bleeding and thromboembolic complications in patients on chronic hemodialysis with the total thrombus-formation analysis system
Patients receiving hemodialysis (HD) are susceptible to bleeding and thrombosis. We assessed whether the T-TAS assay - which measures platelet thrombus formation (PL-AUC) and fibrin-rich thrombus formation (AR-OT) in whole blood under flow - could predict these complications in 176 chronic HD patients, monitoring bleeding and thromboembolic events over one year. During follow-up, 29 patients (16.5%) experienced at least one major or clinically relevant non-major bleeding (CRNMB) event, while 31 patients (17.6%) had at least one thromboembolic event. Patients with low thrombogenicity (PL-AUC below the median) had a more than fivefold increased risk of major bleed/CRNMB in multivariate analyses, and a C-statistic (ROC-AUC; 95% CI) for discrimination between future bleeding/no bleeding of 0.82 (0.74-0.90). AR-OT data showed comparable results. Further, the risk of thromboembolism was significantly lower in patients with PL-AUC below the median (multivariate OddsRisk [OR] ~0.20; C-statistic for thromboembolism/no thromboembolism of 0.73 [0.64-0.83]). Reduced fibrin-rich thrombus formation (AR-OT above median) was associated with ORs below 0.50 to develop thromboembolism in multivariate analyses (C-statistic 0.75 [0.65-0.85]). Excluding patients on oral antithrombotic agents (i.e. aspirin (n = 20) and warfarin (n = 14)), resulted in similar findings. In conclusion, T-TAS is a promising tool for assessing bleeding and thrombosis risk in HD patients.
- 25 January 2026
- Published by Taylor & Francis in Platelets
- Vol. 37 (1) , 2614709
Open AccessPrediction of bleeding and thromboembolic complications in patients on chronic hemodialysis with the total thrombus-formation analysis system
Patients receiving hemodialysis (HD) are susceptible to bleeding and thrombosis. We assessed whether the T-TAS assay - which measures platelet thrombus formation (PL-AUC) and fibrin-rich thrombus formation (AR-OT) in whole blood under flow - could predict these complications in 176 chronic HD patients, monitoring bleeding and thromboembolic events over one year. During follow-up, 29 patients (16.5%) experienced at least one major or clinically relevant non-major bleeding (CRNMB) event, while 31 patients (17.6%) had at least one thromboembolic event. Patients with low thrombogenicity (PL-AUC below the median) had a more than fivefold increased risk of major bleed/CRNMB in multivariate analyses, and a C-statistic (ROC-AUC; 95% CI) for discrimination between future bleeding/no bleeding of 0.82 (0.74-0.90). AR-OT data showed comparable results. Further, the risk of thromboembolism was significantly lower in patients with PL-AUC below the median (multivariate OddsRisk [OR] ~0.20; C-statistic for thromboembolism/no thromboembolism of 0.73 [0.64-0.83]). Reduced fibrin-rich thrombus formation (AR-OT above median) was associated with ORs below 0.50 to develop thromboembolism in multivariate analyses (C-statistic 0.75 [0.65-0.85]). Excluding patients on oral antithrombotic agents (i.e. aspirin (n = 20) and warfarin (n = 14)), resulted in similar findings. In conclusion, T-TAS is a promising tool for assessing bleeding and thrombosis risk in HD patients.
- 1 January 2025
- Published by University Library in Kragujevac
- p. 281-284
Venous congestion and the kidney in cardiorenal syndrome
Hypervolemia is associated with deterioration of renal function and poor prognosis of patients with cardiorenal syndrome. The term congestive nephropathy is related to a disorder of renal function that occur as a result of venous congestion and poor renal perfusion during cardiorenal interaction. The mechanism of congestive nephropathy is multifactorial and complex. It is not possible to fully assess the true intravascular volume by clinical examination. In the assessment of hypervolemia, various markers are used, which are interpreted carefully and in the context of the clinical picture. Of the visualization methods, the most interesting is Doppler ultrasound for assessing volemia and venous circulation in different clinical circumstances. The Doppler index was created as a sum of points obtained by Doppler examination of the inferior vena cava, portal vein, hepatic and renal veins as a means of assessing the degree of hypervolemia and the burden of kidney congestion. One of the goals in the treatment of congestive nephropathy is the control of kidney function, water and electrolyte homeostasis, and hemodynamic disturbance. Future research will resolve doubts about the criteria for the diagnosis of congestive nephropathy, the mechanism of the disease, its recognition, diagnosis and treatment.
- 1 January 2025
- Published by University Library in Kragujevac
- p. 281-284
Venous congestion and the kidney in cardiorenal syndrome
Hypervolemia is associated with deterioration of renal function and poor prognosis of patients with cardiorenal syndrome. The term congestive nephropathy is related to a disorder of renal function that occur as a result of venous congestion and poor renal perfusion during cardiorenal interaction. The mechanism of congestive nephropathy is multifactorial and complex. It is not possible to fully assess the true intravascular volume by clinical examination. In the assessment of hypervolemia, various markers are used, which are interpreted carefully and in the context of the clinical picture. Of the visualization methods, the most interesting is Doppler ultrasound for assessing volemia and venous circulation in different clinical circumstances. The Doppler index was created as a sum of points obtained by Doppler examination of the inferior vena cava, portal vein, hepatic and renal veins as a means of assessing the degree of hypervolemia and the burden of kidney congestion. One of the goals in the treatment of congestive nephropathy is the control of kidney function, water and electrolyte homeostasis, and hemodynamic disturbance. Future research will resolve doubts about the criteria for the diagnosis of congestive nephropathy, the mechanism of the disease, its recognition, diagnosis and treatment.
- Open Access
Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study
Background and Objectives: Patients undergoing chronic hemodialysis (HD) are predisposed to both thrombotic and bleeding complications due to the complex interplay of end-stage renal disease (ESRD), cardiovascular comorbidities, and the routine use of anticoagulant and antiplatelet therapies. This study aimed to investigate the incidence of bleeding and thrombotic events in chronic HD patients receiving anticoagulant and antiplatelet therapy, with a specific focus on those with atrial fibrillation (AF). Materials and Methods: A total of 224 patients, with 43 (19%) of them diagnosed with AF, were included in this single-center, observational cohort study conducted over 24 months. The cohort was divided into three groups: patients without anticoagulation, those on warfarin monotherapy, and those on combined warfarin and aspirin therapy. Bleeding events were classified as major, clinically relevant non-major bleeding (CRNMB), or minor bleeding, while thrombotic events included ischemic stroke, myocardial infarction, pulmonary embolism, and arteriovenous fistula thrombosis. Results: Overall, 35.7% of patients experienced a bleeding event, with major bleeding occurring in 9.4%. Patients with AF had significantly higher rates of major bleeding (18.6%) compared to those without AF (7.18%; p = 0.043), especially in the combined therapy group. Mortality due to bleeding was also higher in AF patients (14%). In contrast, thrombotic events occurred in 26.8% of patients, with AF patients experiencing significantly more events (48.8%) compared to non-AF patients (21.5%; p = 0.0006). The hazard ratio (HR) for major bleeding in patients on combined warfarin and aspirin therapy was 2.56 (p = 0.016), while the HR for thrombotic events was 2.34 (p = 0.0202). Conclusions: These findings highlight the increased risks of both bleeding and thrombosis in chronic HD patients with AF, particularly those on combined anticoagulation and antiplatelet therapy.
Open AccessBleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study
Background and Objectives: Patients undergoing chronic hemodialysis (HD) are predisposed to both thrombotic and bleeding complications due to the complex interplay of end-stage renal disease (ESRD), cardiovascular comorbidities, and the routine use of anticoagulant and antiplatelet therapies. This study aimed to investigate the incidence of bleeding and thrombotic events in chronic HD patients receiving anticoagulant and antiplatelet therapy, with a specific focus on those with atrial fibrillation (AF). Materials and Methods: A total of 224 patients, with 43 (19%) of them diagnosed with AF, were included in this single-center, observational cohort study conducted over 24 months. The cohort was divided into three groups: patients without anticoagulation, those on warfarin monotherapy, and those on combined warfarin and aspirin therapy. Bleeding events were classified as major, clinically relevant non-major bleeding (CRNMB), or minor bleeding, while thrombotic events included ischemic stroke, myocardial infarction, pulmonary embolism, and arteriovenous fistula thrombosis. Results: Overall, 35.7% of patients experienced a bleeding event, with major bleeding occurring in 9.4%. Patients with AF had significantly higher rates of major bleeding (18.6%) compared to those without AF (7.18%; p = 0.043), especially in the combined therapy group. Mortality due to bleeding was also higher in AF patients (14%). In contrast, thrombotic events occurred in 26.8% of patients, with AF patients experiencing significantly more events (48.8%) compared to non-AF patients (21.5%; p = 0.0006). The hazard ratio (HR) for major bleeding in patients on combined warfarin and aspirin therapy was 2.56 (p = 0.016), while the HR for thrombotic events was 2.34 (p = 0.0202). Conclusions: These findings highlight the increased risks of both bleeding and thrombosis in chronic HD patients with AF, particularly those on combined anticoagulation and antiplatelet therapy.
- Open Access
- 23 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (18) , 2094
The Role of Oxidative Stress as a Mechanism in the Pathogenesis of Acute Heart Failure in Acute Kidney Injury
Despite a large amount of research on synchronous and mutually induced kidney and heart damage, the basis of the disease is still not fully clarified. Healthy mitochondria are essential for normal kidney and heart function. Mitochondrial dysfunction occurs when the clearance or process of generation and fragmentation of mitochondria is disturbed. The kidney is the second organ after the heart in terms of the number of mitochondria. Kidney tubules are rich in mitochondria due to the high energy requirements for absorption of large amounts of ultrafiltrate and dissolved substances. The place of action of oxidative stress is the influence on the balance in the production and breakdown of the mitochondrial reactive oxygen species. A more precise determination of the place and role of key factors that play a role in the onset of the disease is necessary for understanding the nature of the onset of the disease and the creation of therapy in the future. This underscores the urgent need for further research. The narrative review integrates results found in previously performed studies that have evaluated oxidative stress participation in cardiorenal syndrome type 3.
- 23 September 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (18) , 2094
Open AccessThe Role of Oxidative Stress as a Mechanism in the Pathogenesis of Acute Heart Failure in Acute Kidney Injury
Despite a large amount of research on synchronous and mutually induced kidney and heart damage, the basis of the disease is still not fully clarified. Healthy mitochondria are essential for normal kidney and heart function. Mitochondrial dysfunction occurs when the clearance or process of generation and fragmentation of mitochondria is disturbed. The kidney is the second organ after the heart in terms of the number of mitochondria. Kidney tubules are rich in mitochondria due to the high energy requirements for absorption of large amounts of ultrafiltrate and dissolved substances. The place of action of oxidative stress is the influence on the balance in the production and breakdown of the mitochondrial reactive oxygen species. A more precise determination of the place and role of key factors that play a role in the onset of the disease is necessary for understanding the nature of the onset of the disease and the creation of therapy in the future. This underscores the urgent need for further research. The narrative review integrates results found in previously performed studies that have evaluated oxidative stress participation in cardiorenal syndrome type 3.
- Open Access
- 22 May 2024
- Published by MDPI AG in Preprints.org
The Role Of Oxidative Stress As A Mechanism In The Pathogenesis Of Heart Failure In Acute Kidney Injury
Despite a large amount of research on synchronous and mutually induced kidney and heart damage, the basis of the disease is still not fully clarified. Healthy mitochondria are essential for normal kidney and heart function. Mitochondrial dysfunction occurs when the clearance or process of generation and fragmentation of mitochondria is disturbed. The kidney is the second organ after the heart in the number of mitochondria. Kidney tubules are rich in mitochondria due to the high energy requirements for absorption processes of large amounts of ultrafiltrate and dissolved substances. The place of action of oxidative stress is the influence on the balance in the production and breakdown of mitochondrial reactive oxygen species . A more precise determination of the place and role of key factors that play a role in the onset of the disease is necessary for understanding the nature of the onset of the disease and the creation of therapy in the future. The narrative review integrates results found in previously performed studies which have evaluated oxidative stress participation in renocardial syndrome type 3.
- 22 May 2024
- Published by MDPI AG in Preprints.org
Open AccessThe Role Of Oxidative Stress As A Mechanism In The Pathogenesis Of Heart Failure In Acute Kidney Injury
Despite a large amount of research on synchronous and mutually induced kidney and heart damage, the basis of the disease is still not fully clarified. Healthy mitochondria are essential for normal kidney and heart function. Mitochondrial dysfunction occurs when the clearance or process of generation and fragmentation of mitochondria is disturbed. The kidney is the second organ after the heart in the number of mitochondria. Kidney tubules are rich in mitochondria due to the high energy requirements for absorption processes of large amounts of ultrafiltrate and dissolved substances. The place of action of oxidative stress is the influence on the balance in the production and breakdown of mitochondrial reactive oxygen species . A more precise determination of the place and role of key factors that play a role in the onset of the disease is necessary for understanding the nature of the onset of the disease and the creation of therapy in the future. The narrative review integrates results found in previously performed studies which have evaluated oxidative stress participation in renocardial syndrome type 3.
- Open Access
- 28 February 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (3) , 437
Data Analysis of Impaired Renal and Cardiac Function Using a Combination of Standard Classifiers
We examine the significance of the predictive potential of EPI cystatin C (EPI CysC) in combination with NTproBNP, sodium, and potassium in the evaluation of renal function in patients with cardiorenal syndrome using standard mathematical classification models from the domain of artificial intelligence. The criterion for the inclusion of subjects with combined impairment of heart and kidney function in the study was the presence of newly discovered or previously diagnosed clinically manifest cardiovascular disease and acute or chronic kidney disease in different stages of evolution. In this paper, five standard classifiers from the field of machine learning were used for the analysis of the obtained data: ensemble of neural networks (MLP), ensemble of k-nearest neighbors (k-NN) and naive Bayes classifier, decision tree, and a classifier based on logistic regression. The results showed that in MLP, k-NN, and naive Bayes, EPI CysC had the highest predictive potential. Thus, our approach with utility classifiers recognizes the essence of the disorder in patients with cardiorenal syndrome and facilitates the planning of further treatment.
- 28 February 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (3) , 437
Open AccessData Analysis of Impaired Renal and Cardiac Function Using a Combination of Standard Classifiers
We examine the significance of the predictive potential of EPI cystatin C (EPI CysC) in combination with NTproBNP, sodium, and potassium in the evaluation of renal function in patients with cardiorenal syndrome using standard mathematical classification models from the domain of artificial intelligence. The criterion for the inclusion of subjects with combined impairment of heart and kidney function in the study was the presence of newly discovered or previously diagnosed clinically manifest cardiovascular disease and acute or chronic kidney disease in different stages of evolution. In this paper, five standard classifiers from the field of machine learning were used for the analysis of the obtained data: ensemble of neural networks (MLP), ensemble of k-nearest neighbors (k-NN) and naive Bayes classifier, decision tree, and a classifier based on logistic regression. The results showed that in MLP, k-NN, and naive Bayes, EPI CysC had the highest predictive potential. Thus, our approach with utility classifiers recognizes the essence of the disorder in patients with cardiorenal syndrome and facilitates the planning of further treatment.
- Open Access
- 12 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3131
Is It Possible to Analyze Kidney Functions, Electrolytes and Volemia Using Artificial Intelligence?
Markers used in everyday clinical practice cannot distinguish between the permanent impairment of renal function. Sodium and potassium values and their interdependence are key parameters in addition to volemia for the assessment of cardiorenal balance. The aim of this study was to investigate volemia and electrolyte status from a clinical cardiorenal viewpoint under consideration of renal function utilizing artificial intelligence. In this paper, an analysis of five variables: B-type natriuretic peptide, sodium, potassium, ejection fraction, EPI creatinine-cystatin C, was performed using an algorithm based on the adaptive neuro fuzzy inference system. B-type natriuretic peptide had the greatest influence on the ejection fraction. It has been shown that values of both Na+ and K+ lead to deterioration of the condition and vital endangerment of patients. To identify the risk of occurrence, the model identifies a prognostic biomarker by random regression from the total data set. The predictions obtained from this model can help optimize preventative strategies and intensive monitoring for patients identified as at risk for electrolyte disturbance and hypervolemia. This approach may be superior to the traditional diagnostic approach due to its contribution to more accurate and rapid diagnostic interpretation and better planning of further patient treatment
- 12 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (12) , 3131
Open AccessIs It Possible to Analyze Kidney Functions, Electrolytes and Volemia Using Artificial Intelligence?
Markers used in everyday clinical practice cannot distinguish between the permanent impairment of renal function. Sodium and potassium values and their interdependence are key parameters in addition to volemia for the assessment of cardiorenal balance. The aim of this study was to investigate volemia and electrolyte status from a clinical cardiorenal viewpoint under consideration of renal function utilizing artificial intelligence. In this paper, an analysis of five variables: B-type natriuretic peptide, sodium, potassium, ejection fraction, EPI creatinine-cystatin C, was performed using an algorithm based on the adaptive neuro fuzzy inference system. B-type natriuretic peptide had the greatest influence on the ejection fraction. It has been shown that values of both Na+ and K+ lead to deterioration of the condition and vital endangerment of patients. To identify the risk of occurrence, the model identifies a prognostic biomarker by random regression from the total data set. The predictions obtained from this model can help optimize preventative strategies and intensive monitoring for patients identified as at risk for electrolyte disturbance and hypervolemia. This approach may be superior to the traditional diagnostic approach due to its contribution to more accurate and rapid diagnostic interpretation and better planning of further patient treatment
- Open Access
- 2 April 2022
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (10) , 2695-2702
Platelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis system
Background: Patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) often experience bleeding. However, mechanisms behind this bleeding tendency are incompletely understood but may involve platelet dysfunction. We, therefore, studied platelet-dependent thrombus formation in flowing whole blood inside a microchip coated with collagen, and its association with circulating von Willebrand factor (VWF). Methods: Blood samples were obtained in 22 patients before and after HD. The area under the 10 min flow pressure curve in a microchip (AUC10) reflecting total platelet thrombogenicity was measured, using the Total Thrombus-formation Analysis System (T-TAS01). AUC10 < 260 indicates platelet dysfunction. VWF activity and antigen in plasma were also assayed. Results: VWF levels were moderately elevated and increased further after HD (P < 0.01 or lower). In contrast, AUC10 before and after HD was < 260 in 17/22 patients and < 130 in 15/22 patients, with no statistically significant difference in pre- vs post-HD measurements, indicating reduced platelet thrombogenicity, but with some variability as 5/22 patients showed normal platelet responsiveness. AUC10 and VWF activity or antigen levels in plasma were not correlated, either before or after HD. Conclusions: Most ESRD patients display moderate-to-severe platelet dysfunction as assessed by shear-induced platelet-dependent thrombus formation with T-TAS01. HD does not influence platelet function despite HD-induced elevations in VWF. T-TAS01 should be further evaluated as a tool in the assessment of bleeding risk in patients on HD. Graphical
- 2 April 2022
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (10) , 2695-2702
Open AccessPlatelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis system
Background: Patients with end-stage renal disease (ESRD) receiving hemodialysis (HD) often experience bleeding. However, mechanisms behind this bleeding tendency are incompletely understood but may involve platelet dysfunction. We, therefore, studied platelet-dependent thrombus formation in flowing whole blood inside a microchip coated with collagen, and its association with circulating von Willebrand factor (VWF). Methods: Blood samples were obtained in 22 patients before and after HD. The area under the 10 min flow pressure curve in a microchip (AUC10) reflecting total platelet thrombogenicity was measured, using the Total Thrombus-formation Analysis System (T-TAS01). AUC10 < 260 indicates platelet dysfunction. VWF activity and antigen in plasma were also assayed. Results: VWF levels were moderately elevated and increased further after HD (P < 0.01 or lower). In contrast, AUC10 before and after HD was < 260 in 17/22 patients and < 130 in 15/22 patients, with no statistically significant difference in pre- vs post-HD measurements, indicating reduced platelet thrombogenicity, but with some variability as 5/22 patients showed normal platelet responsiveness. AUC10 and VWF activity or antigen levels in plasma were not correlated, either before or after HD. Conclusions: Most ESRD patients display moderate-to-severe platelet dysfunction as assessed by shear-induced platelet-dependent thrombus formation with T-TAS01. HD does not influence platelet function despite HD-induced elevations in VWF. T-TAS01 should be further evaluated as a tool in the assessment of bleeding risk in patients on HD. Graphical
- Open Access
- 28 December 2021
- Published by Springer Nature in Research Square
Monitoring of Kidney Functions, Electrolytes and Volemia Analyzed by Application Example of Artificial Intelligence in Patients with Heart Failure
Basal renal function is a predictor of response to diuretic therapy and marker of poor prognosis. Simultaneous changes in renal function, sodium, potassium values and their interdependence are key parameters in addition to volemia for the assessment of cardiorenal balance. In our paper, an analysis of volemia, electrolytes, and renal function in heart failure was performed using an algorithm based on the ANFIS (Adoptive Neural Fuzzy Inference System), an intelligent approach to renal and heart function monitoring. The study included 90 subjects who were divided into two groups: clinical (n-80) and control (n-10). The base is composed of parameters B-type natriuretic peptide (NT-proBNP), sodium (Na), potassium (K), ejection fraction (EF), EPI creatinine-cystatin C formula and ANFIS expert system combined in neural network and fuzzy logic network. The results showed that the overall trend of data verification in the network with NT-proBNP, Na and K that we formed is approximately 15%, with which subjects can be classified according to the severity of hypervolemia, electrolyte disturbance and renal function. NT-proBNP (pg/mL) had the most influence on the EPI creatinine-cystatin C formula. Serum sodium (Na) has the most influence on the ejection fraction (EF).
- 28 December 2021
- Published by Springer Nature in Research Square
Open AccessMonitoring of Kidney Functions, Electrolytes and Volemia Analyzed by Application Example of Artificial Intelligence in Patients with Heart Failure
Basal renal function is a predictor of response to diuretic therapy and marker of poor prognosis. Simultaneous changes in renal function, sodium, potassium values and their interdependence are key parameters in addition to volemia for the assessment of cardiorenal balance. In our paper, an analysis of volemia, electrolytes, and renal function in heart failure was performed using an algorithm based on the ANFIS (Adoptive Neural Fuzzy Inference System), an intelligent approach to renal and heart function monitoring. The study included 90 subjects who were divided into two groups: clinical (n-80) and control (n-10). The base is composed of parameters B-type natriuretic peptide (NT-proBNP), sodium (Na), potassium (K), ejection fraction (EF), EPI creatinine-cystatin C formula and ANFIS expert system combined in neural network and fuzzy logic network. The results showed that the overall trend of data verification in the network with NT-proBNP, Na and K that we formed is approximately 15%, with which subjects can be classified according to the severity of hypervolemia, electrolyte disturbance and renal function. NT-proBNP (pg/mL) had the most influence on the EPI creatinine-cystatin C formula. Serum sodium (Na) has the most influence on the ejection fraction (EF).